Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ribociclib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Lee011 succinate, 1374639-75-4, Lee-011 succinate, Lee011-bba, Ribociclib succinate [usan], Kisqali
    Molecular Formula
    C27H36N8O5
    Molecular Weight
    552.6  g/mol
    InChI Key
    NHANOMFABJQAAH-UHFFFAOYSA-N
    FDA UNII
    BG7HLX2919
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    butanedioic acid;7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide
    2.1.2 InChI
    InChI=1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8)
    2.1.3 InChI Key
    NHANOMFABJQAAH-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5.C(CC(=O)O)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    BG7HLX2919
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Kisqali

    2. Lee011

    3. Ribociclib

    2.3.2 Depositor-Supplied Synonyms

    1. Lee011 Succinate

    2. 1374639-75-4

    3. Lee-011 Succinate

    4. Lee011-bba

    5. Ribociclib Succinate [usan]

    6. Kisqali

    7. Lee-011-bba

    8. Bg7hlx2919

    9. 7-cyclopentyl-n,n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide Succinate

    10. Butanedioic Acid;7-cyclopentyl-n,n-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide

    11. Ribociclib Succinate (usan)

    12. Butanedioic Acid, Compd. With 7-cyclopentyl-n,n-dimethyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-7h-pyrrolo(2,3-d)pyrimidine-6-carboxamide (1:1)

    13. Butanedioic Acid, Compd. With 7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1:1)

    14. Unii-bg7hlx2919

    15. Kisqali (tn)

    16. Lee011 (succinate)

    17. Birociclib [who-dd]

    18. Schembl2684999

    19. Chembl3707266

    20. Ribociclib Succinate [mi]

    21. Dtxsid301027923

    22. Amy25508

    23. Bcp12715

    24. Ex-a1586

    25. Zec63975

    26. Lee011 Succinatelee011 Succinate

    27. Hy-15777b

    28. S5188

    29. Ribociclib Succinate [who-dd]

    30. Sb18482

    31. Ac-30654

    32. As-75241

    33. Ribociclib Succinate [orange Book]

    34. D10979

    35. Lee-011 Succinate Salt, Ribociclib Succinate Salt

    36. J-007026

    37. Q27274660

    38. Kisqali Femara Co-pack Component Ribociclib Succinate

    39. Ribociclib Succinate Component Of Kisqali Femara Co-pack

    40. 7-cyclopentyl-n,n-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide; Butanedioic Acid

    2.4 Create Date
    2012-06-20
    3 Chemical and Physical Properties
    Molecular Weight 552.6 g/mol
    Molecular Formula C27H36N8O5
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count8
    Exact Mass552.28086628 g/mol
    Monoisotopic Mass552.28086628 g/mol
    Topological Polar Surface Area166 Ų
    Heavy Atom Count40
    Formal Charge0
    Complexity728
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameKISQALI
    Active IngredientRIBOCICLIB SUCCINATE
    CompanyNOVARTIS PHARMS CORP (Application Number: N209092. Patents: 8324225, 8415355, 8685980, 8962630, 9193732, 9416136, 9868739)

    2 of 2  
    Drug NameKISQALI FEMARA CO-PACK (COPACKAGED)
    Active IngredientLETROZOLE; RIBOCICLIB SUCCINATE
    CompanyNOVARTIS PHARMS CORP (Application Number: N209935. Patents: 8324225, 8415355, 8685980, 8962630, 9193732, 9416136, 9868739)

    4.2 Drug Indication

    Kisqali is indicated for the treatment of women with hormone receptor (HR)positive, human epidermal growth factor receptor 2 (HER2)negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy.

    In pre or perimenopausal women, the endocrine therapy should be combined with a luteinising hormonereleasing hormone (LHRH) agonist.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    L01XE